BVS - CIK 0001665988
Bioventus Inc. (BVS) reported revenue of $568.09M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $568.09M | -0.9% |
| FY 2024 | $573.28M | +11.9% |
| FY 2023 | $512.35M | +0.0% |
| FY 2022 | $512.12M | +18.8% |
| FY 2021 | $430.90M | +34.2% |
| FY 2020 | $321.16M | -5.6% |
| FY 2019 | $340.14M | - |
Bioventus Inc. (BVS) reported revenue of $568.09M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, Bioventus Inc.'s revenue grew from $340.14M to $568.09M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.